There were 488 press releases posted in the last 24 hours and 387,942 in the last 365 days.

Six Research Teams Receive Intermountain-Stanford Grant Award

The collaborative grants provide seed funding for projects aimed at transforming healthcare in multiple fields of medicine

SALT LAKE CITY, UTAH, USA, August 18, 2017 / -- Stanford Medicine and Intermountain Healthcare have announced the recipients of more than $400,000 in seed grants focused on transforming healthcare.

The six projects were chosen from a competitive field of 23 proposals, using a vetting process similar to that used by the National Institutes of Health, which establishes selection criteria and scoring systems.

“The Intermountain-Stanford grant program is part of an exciting collaboration focused on advancing clinical care best practices, education and training, and clinical research in heart disease, cancer, and other conditions. This is the second year of the grant program, in September 2016 seven grants were awarded and those projects are underway. The purpose of the grant award is to spearhead and accelerate research between the two organizations and support innovative projects in research, patient care, and medical education” says Robert W. Allen, Intermountain Healthcare’s Senior Vice President and Chief Operating Officer.

“Our collaboration will foster those scientific discoveries that have potential to improve patient care in both institutions,” says David Larson, MD, MBA, co-chair of the Intermountain-Stanford Collaborative Committee and Stanford University School of Medicine’s Associate Professor of Pediatric Radiology and Associate Chair of Performance Improvement in the Department of Radiology.

The seed grants, up to $75,000 each, were awarded to projects that will be jointly led by principal investigators from Intermountain and Stanford, and will take effect on September 1, 2017.

The six selected projects focus on surgical health services, emergency medicine and electronic decision support, pediatric bronchiolitis, neonatal onset of sepsis, team-based primary care, and infectious disease. Although they’re from diverse clinical areas, all the studies are designed to improve patient care.

The six selected projects:

• Setting a foundation for collaborative surgical health services research at Stanford Health Care, Intermountain Healthcare, and the Veterans Health Administration — Stephen Warner, MD, Orthopedic Surgery, Intermountain Healthcare; Alex Sox-Harris, PhD, MS, Associate Professor (Research) of Surgery, Stanford.

• ePE: Electronic decision support for the diagnosis and treatment of acute pulmonary embolism in the emergency department — Joseph Bledsoe, MD, FACEP, Medical Director Emergency Medicine/Trauma, Intermountain Healthcare; Ian Brown, MD, MS, FAAEM, FACEP, Clinical Assistant Professor, Emergency Medicine, Stanford.

• Optimizing value in bronchiolitis: the bronchiolitis follow-up intervention trial (BeneFIT) — Eric Coon, MD, MS, Pediatric Medicine, Intermountain Primary Children’s Hospital; Alan Schroeder, MD, Associate Chief for Research in the Division of Pediatric Hospital Medicine at Lucile Packard Children’s Hospital Stanford.

• Early detection of neonatal early onset sepsis using the sepsis MetaScore: A genomic analysis of cord blood — Patrick Carroll, MD, MPH, Neonatology, Intermountain Healthcare; Purvesh Khatri, PhD, Assistant Professor (Research) of Medicine (Biomedical Informatics Research-ITI Institute) and of Biomedical Data Science, Stanford.

• Pragmatic Design for Enhanced Team-Based Primary Care — Brenda Reiss-Brennan, PhD, APRN, Behavioral Health Services Director, Intermountain Healthcare; Marcy Winget, PhD, Director, Evaluation Sciences Unit and Clinical Associate Professor in the Division of Primary Care and Population Health, Stanford School of Medicine.

• Repurposing an old drug for a new epidemic: ursodeoxycholic acid and clostridium difficile Infection — Brandon Webb, MD, Infectious Diseases, Intermountain Healthcare; Aruna Subramanian, MD, Clinical Associate Professor, Medicine - Infectious Diseases, Stanford.

“We are privileged to collaborate with the Stanford University School of Medicine, a premier medical school and worldwide leader in science and research,” says Raj Srivastava, MD, MPH, co-chair of the Intermountain-Stanford Collaborative Committee and AVP of Research at Intermountain Healthcare. “We are excited to launch these projects, foster new scientific collaborations focused on improving patient care, and set the stage for the healthcare transformation potential from the Intermountain-Stanford grant program.”

Intermountain Healthcare is a Utah-based, not-for-profit system of 22 hospitals, 180 clinics, a Medical Group with some 1,500 employed physicians, a health plans division called SelectHealth, and other health services. Helping people live the healthiest lives possible, Intermountain is widely recognized as a leader in transforming healthcare through high quality and sustainable costs. For more information about Intermountain, visit,

Daron Cowley
Intermountain Healthcare
email us here